在PFAPA综合征中胆固醇预防疗法的有效性:一个比较队列研究
Rim Kasem AliSliman1, Stav Regev2, Basel Ghanim2
1Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Department of Pediatrics, Carmel Medical Center, Haifa, Israel.
Seminars in arthritis and rheumatism
|February 15, 2026
概括
科尔奇辛的预防可显著降低PFAPA (周期性发烧,口腔炎,喉炎,腺炎) 发作频率. 这种治疗提供了一种预防方法,独立于遗传状态,从反应性护理转变为预防.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- PFAPA综合征是儿童最常见的周期性发烧,导致经常性发烧.
- 目前的治疗方法,如皮质类固醇治疗症状,但不能防止未来的攻击或解决炎症.
- 皮质类固醇在长期使用时会带来潜在的副作用.
研究的目的:
- 评估菌素在预防PFAPA发作和延长无症状期间的有效性.
- 为了比较胆固醇预防与PFAPA患者的标准护理.
主要方法:
- 一项对55名儿科PFAPA患者进行的回顾性队列研究.
- 15名患者接受了素预防治疗;40名患者接受了标准护理.
- 主要结局:发作之间的时间变化;次要:FMF遗传状态的影响.
主要成果:
- 与对照组 (0天) 相比,科尔奇辛组在PFAPA发作之间的间隔显著更长 (中位数为60天).
- 不管FMF (家族地中海热) 的遗传状况如何,科尔奇辛的益处都被观察到.
- 基线特征相似,但FMF突变的患病率在菌素组中更高.
结论:
- 科尔奇辛预防有效地减少了PFAPA攻击频率.
- 益处独立于FMF遗传状况,支持其在多样化的PFAPA种群中使用.
- 代表着向PFAPA主动,预防性管理的转变,特别是对于频繁或对类固醇敏感的病例.
相关概念视频
Pharmacogenomics: Identification of New Drug Targets
9
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
9
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
15
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
15
